OMT for smell loss after COVID-19
Part of Brain & nervous system clinical trials.
This trial tests if osteopathic manipulative treatment (OMT) can help people regain their sense of smell after COVID-19. OMT is a hands-on therapy used by osteopathic doctors to improve body function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a positive COVID-19 test or were told you had COVID-19.
- You have noticed a reduced sense of smell since having COVID-19.
- You are 18 years of age or older.
- You are not pregnant.
- You are not using certain nasal sprays or medications that affect smell, like intranasal zinc, antihistamines, or corticosteroids, and you do not have allergic rhinitis.
- You are not taking oral corticosteroids or antihistamines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether structured smell (olfactory) training can improve ongoing smell problems after COVID-19. It may help people whose sense of smell hasn’t fully returned long after the infection.
This study uses brain imaging and electrical recordings to understand the brain's role in smell loss from any cause—like COVID, sinus problems, or chemotherapy. You may be eligible if you have any degree of smell loss lasting under a year.
This study tests whether structured smell “training” can improve smell problems. It’s mainly for people who have had reduced smell for more than 6 months but less than 5 years.
This study tests whether a special device can help older adults regain their sense of smell through regular training with different scents. It is designed for people who have lost smell due to aging or other causes, not from birth.
This trial studies whether daily smell training can improve smell loss caused by COVID-19. It may help people regain smell and possibly reduce related symptoms like distorted smells.
This study looks at why some people lose or change their sense of smell after COVID-19. Researchers will take a tiny sample of tissue from your nose to study the cells and molecules involved.
Hear when a new Anosmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.